Emerging Pharmaceutical Market in China Reviewed in New GBI Research Report Published by MarketPublishers.com

23 Sep 2011 • by Natalie Aster
Emerging Pharmaceutical Market in China Reviewed in New GBI Research Report Published by MarketPublishers.com

LONDON – Among the 17 pharmerging markets, China takes the lead and is forecast to become the world's third-largest pharmaceutical market next year, which is a big improvement from its position as number 8 in 2006. The country’s revenues are set to increase over USD 40 billion by 2013. Most of the rise will be in branded generic products from domestic companies, while innovative pharmaceutical products from multinationals will flourish in China’s largest urban centers.

New research report “Emerging Pharmaceutical Market in China - Forecast to Become The World’s Third-Largest Pharmaceutical Market By 2013” elaborated by GBI Research provides a detailed analysis of trends, issues and challenges pertaining to China’s emerging pharmaceutical industry, covering overall pharma, biotech and outsourcing market structure, trends shaping the industry dynamics, key market drivers and barriers. Furthermore, valuable information on the competitive landscape along with profiles of leading market players as well as evaluation of major M&A activities and strategic partnership deals having taken place in 2009 can also be found in the study.

Report Details:

Title: Emerging Pharmaceutical Market in China - Forecast to Become The World’s Third-Largest Pharmaceutical Market By 2013
Published: September, 2011
Pages: 85
Price: US$ 3,500.00

Contents:

1 TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures

2 EMERGING PHARMACEUTICAL MARKET: CHINA – INTRODUCTION
2.1 GBI Research Report Guidance

3 EMERGING PHARMACEUTICAL MARKET: CHINA – MACROECONOMIC ENVIRONMENT
3.1 Demographic Analysis
3.2 PEST Analysis
  3.2.1 Political Factors
  3.2.2 Economic Factors
  3.2.3 Social Factors
  3.2.4 Technological Factors

4 EMERGING PHARMACEUTICAL MARKET: CHINA – INDUSTRY PERFORMANCE
4.1 China (Past, Present and Future Scenario)
  4.1.1 Macroeconomic Indicators
  4.1.2 Population Profile
  4.1.3 Environmental Burden of Disease
  4.1.4 Healthcare Spending and Financing
  4.1.5 Imports and Exports
  4.1.6 Branded and Generic Drugs
  4.1.7 Healthcare Infrastructure

5 EMERGING PHARMACEUTICAL MARKET: CHINA – PHARMA AND BIOTECH INDUSTRY
5.1 Pharmaceutical Market Size and Growth in China
5.2 Biotech Market Size and Growth in China
5.3 Major Regulatory Bodies in China
  5.3.1 SFDA (State Food and Drug Administration)
  5.3.2 CDE (Center for Drug Evaluation)
  5.3.3 NDRC (National Development and Reform Commission)
  5.3.4 NICPBP (National Institute for the Control of Pharmaceutical and Biological Products)

To order the report or ask for free sample pages, please contact ps@marketpublishers.com

 

CONTACTS

The Market Publishers, Ltd.

Tanya Rezler

Tel: +44 208 144 6009

Fax: +44 207 900 3970

ps@marketpublishers.com

www.marketpublishers.com